Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation
Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation have?
Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation has 2,178 citations in the OpenAlex counts ScholarIQ stores.
When was Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation published?
Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation has 2018 year in the ScholarIQ index.
What is the open-access status of Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation?
Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation has green oa status in the ScholarIQ index.
What is the DOI of Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation?
The DOI for Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation is on the source record.
What is the PMID of Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation?
The PMID for Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation is on the source record.
What is the OpenAlex record for Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation?
The OpenAlex for Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation is on the source record.